Neuropathology and behavioral impairments in Wistar rats with a 6-OHDA lesion in the substantia nigra compacta and exposure to a static magnetic field

References

• Ahmad S, Khan MB, Hoda MN, Bhatia K, Haque R, Fazili IS, Jamal A, . 2012. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence. Neurochem Res.. 37 3: 516–526.
   PubMed Web of Science ®Google Scholar
• Bertolino G, de Freitas Braga A, de Oliveira Lima do Couto Rosa K, de Brito Junior LC, de Araujo JE. 2006. Macroscopic and histological effects of magnetic field exposition in the process of tissue reparation in Wistar rats. Arch Dermatol Res.. 298 3: 121–126.
   PubMed Web of Science ®Google Scholar
• Blum D, Torch S. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol.. 65 2: 135–172LambengNNissouMBenabidALSadoulRVernaJM.
   PubMed Web of Science ®Google Scholar
• Buiatti de Araujo FL, Bertolino G, Rodrigues Funayama CA, Coimbra NC, Eduardo de Araujo J. 2008. Influence of treadmill training on motor performance and organization of exploratory behavior in Meriones unguiculatus with unilateral ischemic stroke: histological correlates in hippocampal CA1 region and the neostriatum. Neurosci Lett.. 431 2: 179–183.
   PubMed Web of Science ®Google Scholar
• Chen HH, Lin SC, Chan MH. 2011. Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism. Neurodegener Dis.. 8 5: 364–374.
   PubMed Web of Science ®Google Scholar
• de Araujo FL, Bertolino G. 2012. Neuropathology and behavioral impairments after three types of global ischemia surgery in Meriones unguiculatus: evidence in motor cortex, hippocampal CA1 region and the neostriatum. J Neurol Sci.. 312 1–2: 73–78GonçalvesRBMariLdeCCoimbraNCdeAraujoJE.
   PubMed Web of Science ®Google Scholar
• Eremenko T, Esposito C, Pasquarelli A, Pasquali E, Volpe P. 1997. Cell-cycle kinetics of friend erythroleukemia cells in a magnetically shielded room and in a low-frequency/low-intensity magnetic field. Bioelectromagnetics. 18 1: 58–66.
   PubMed Web of Science ®Google Scholar
• Fanelli C, Coppola S, Barone R, Colussi C, Gualandi G, Volpe P, Ghibelli L. 1999. Magnetic fields increase cell survival by inhibiting apoptosis via modulation of Ca2+ influx. FASEB J.. 13 1: 95–102.
   PubMed Web of Science ®Google Scholar
• Fornaguera J, Schwarting RKW. 2002. Time course of deficits in open field behavior after unilateral neostriatal 6-hydroxydopamine lesions. Neurotox Res.. 4 1: 41–49.
   PubMed Web of Science ®Google Scholar
• Hritcua L, Foyet HS, Stefan M, Mihasan M, Asongalem AE, Kamtchouing P. 2011. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. J Ethnopharmacol. 137 1: 585–591.
   PubMed Web of Science ®Google Scholar
• Kumar R, Agarwal ML, Seth PK. 1995. Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem.. 64 4: 1703–1707.
   PubMed Web of Science ®Google Scholar
• Liburdy RP. 1992. Calcium signaling in lymphocytes and ELF field: evidence for an electric field metric and a site of interaction involving the calcium ion channel. FEBS Lett.. 301 1: 53–5913.
   PubMed Web of Science ®Google Scholar
• Liburdy RP, Callahan DE, Harland J, Dunham E, Sloma TR, Yaswen P. 1993. Experimental evidence for 60 Hz magnetic fields operating through the signal transduction cascade: effects on calcium influx and c-myc mRNA induction. FEBS Lett.. 334 3: 301–30822.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang H. 2011. S100B transgenic mice develop features of Parkinson's disease. Arch Med Res.. 42 1: 1–7ZhangLXuYDengWZhuHQC.
   PubMed Web of Science ®Google Scholar
• Medina FJ, Túnez I. 2010. Huntington's disease: the value of transcranial meganetic stimulation. Curr Med Chem.. 17 23: 2482–2491.
   PubMed Web of Science ®Google Scholar
• Monville C, Torres EM, Dunnett SB. 2006. Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J Neurosci Methods.. 158 2: 219–22315.
   PubMed Web of Science ®Google Scholar
• Oestreicher E, Sengstock GJ, Riederer P, Olanow CW, Dunn AJ, Arendash GW. 1994. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study. Brain Res.. 660 1: 8–1810.
   PubMed Web of Science ®Google Scholar
• Paradisi S, Donelli G, Santini MT, Straface E, Malorni W. 1993. A 50 Hz magnetic field induces structural and biophysical changes in membranes. Bioelectromagnetics. 14 3: 247–255.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. New York: Academic Press.
   Google Scholar
• Phillips JL, Haggren W, Thomas WJ, Ishida-Jones T, Adey WR. 1992. Magnetic field-induced changes in specific gene transcription. Biochim Biophys Acta.. 1132 2: 140–14424.
   PubMed Web of Science ®Google Scholar
• Rodrigues RW, Gomide V, Chadi G. 2001. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int J Neurosci.. 109 1–2: 91–126.
   PubMed Web of Science ®Google Scholar
• Rosen AD. 2003. Mechanism of action of moderate-intensity static magnetic fields on biological systems. Cell Biochem Biophys.. 39 2: 163–173.
   PubMed Web of Science ®Google Scholar
• Tajiri N, Yasuhara T. 2010. Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res.. 1310:200–207ShgoTKondoAYuanWKadotaTWangF.
   PubMed Web of Science ®Google Scholar
• Tasset I, Pérez-Herrera A, Medina FJ, Arias-Carrión O, Drucker-Colín R, Túnez I. Extremely low-frequency electromagnetic fields activate the antioxidant pathway Nrf2 in a Huntington's disease-like rat model. Brain Stimul.. 201215.
   PubMedGoogle Scholar
• Teodori L, Grabarek J, Smolewski P, Ghibelli L, Bergamaschi A, De Nicola M, Darzynkiewicz Z. 2002. Exposure of cells to static magnetic fields accelerates loss of integrity of plasma membrane during apoptosis. Cytometry. 49:113–118.
   PubMedGoogle Scholar
• Túnez I, Drucker-Colín R, Jimena I, Medina FJ, Muñoz Mdel C, Peña J, Montilla P. 2006. Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease. J Neurochem.. 97 3: 619–630.
   PubMed Web of Science ®Google Scholar
• Ungerstedt U. 1968. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol.. 5:107–110.
   PubMed Web of Science ®Google Scholar
• Vieyra-Reyes P, Mineur YS, Picciotto MR, Túnez I, Vidaltamayo R, Drucker-Colín R. 2008. Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Res Bull.. 77 1: 13–18.
   PubMed Web of Science ®Google Scholar
• Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, Cohen JA, . 2003. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil.. 84:736–746.
   PubMed Web of Science ®Google Scholar